FindTrial
Sign In

A prospective randomized controlled study based on the mathematical model to predict the dose of heparin anticoagulation in the blood purification

A prospective randomized controlled study based on the mathematical model to predict the dose of heparin anticoagulation in the blood purification

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IND-17014192
Enrollment
Unknown
Registered
2017-12-28
Start date
2017-12-30
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney failure and other needs for blood purification

Interventions

Different heparin dose blood purification treatment group:Doses of different heparin

Sponsors

Second Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients receiving CRRT; 2. No coagulant function disorder and its own platelet abnormality; 3. Complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Long-term oral anticoagulant drugs; 2. Inhibitions of heparin anticoagulation; 3. Do not agree to participate in this study.

Design outcomes

Primary

MeasureTime frame
Blood clot routine;Dialyzer and dialysis pipeline coagulation grade;The patient was transmembrane pressure, lower pressure of filter and the pressure of the loop vein;In vitro circulation pipeline, filter and intravenous small pot blood and blood filter machine alarm;Patients hemorrhage and metabolic complications occurred;—

Countries

China

Contacts

Public ContactChunyan Liu

Second Hospital of Dalian Medical University

15541117239@163.com+86 17709870388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026